journal article·2023-02-22

Gold Nanorods Inhibit Tumor Metastasis by Regulating MMP-9 Activity: Implications for Radiotherapy

Ying Shi, Kefeng Pu, Haodong Yao, Yingting Chen, Xuewen Zheng, Lina Zhao, Xiaochuan Ma, Cuicui Ge

Publisher page

Abstract

Dysregulation of matrix metalloproteinase (MMP) is strongly implicated in tumor invasion and metastasis. Nanomaterials can interact with proteins and have impacts on protein activity, which provides a potential strategy for inhibiting tumor invasion and metastasis. However, the regulation of MMP activity by nanomaterials has not been fully determined. Herein, we have found that gold nanorods (Au NRs) are able to induce the change of the secondary structure of MMP-9 and thereby inhibit their activity. Interestingly, the inhibition of MMP-9 activity is highly dependent on the aspect ratio of Au NRs, and an aspect ratio of 3.3 shows the maximum inhibition efficiency. Molecular dynamics simulations combined with mathematical statistics algorithm reveal the binding behaviors and interaction modes of MMP-9 with Au NRs in atomic details and disclose the mechanism of aspect ratio-dependent inhibition effect of Au NRs on MMP-9 activity. Au NRs with an aspect ratio of 3.3 successfully suppress the X-ray-activated invasion and metastasis of tumor by inhibiting MMP-9 activity. Our findings provide important guidance for the modulation of MMP-9 activity by tuning key parameters of nanomaterials and demonstrate that gold nanorods could be developed as potential MMP inhibitors.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Protease and Inhibitor Mechanisms · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) & Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China

Nano-Bio-Chem Centre, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou 215123, China

Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Chinese Academy of Sciences, Beijing 100190, China

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China

References (50)

Show source-provided references
1. 10.1016/j.tips.2017.11.00310.1016/j.tips.2017.11.003 ↗
2. 10.2147/ijn.s29043810.2147/ijn.s290438 ↗
3. 10.1200/jco.2014.55.069910.1200/jco.2014.55.0699 ↗
4. 10.1002/adma.20180224410.1002/adma.201802244 ↗
5. 10.1016/j.cej.2021.13232810.1016/j.cej.2021.132328 ↗
6. 10.1016/j.tips.2017.11.00310.1016/j.tips.2017.11.003 ↗
7. 10.3390/cancers1208202110.3390/cancers12082021 ↗
8. 10.1016/j.critrevonc.2014.05.00610.1016/j.critrevonc.2014.05.006 ↗
9. 10.1158/0008-5472.can-03-246410.1158/0008-5472.can-03-2464 ↗
10. 10.1016/j.biopha.2018.08.02610.1016/j.biopha.2018.08.026 ↗
11. 10.1371/journal.pone.001122210.1371/journal.pone.0011222 ↗
12. 10.1038/sj.onc.120970610.1038/sj.onc.1209706 ↗
13. 10.1007/s13277-015-4352-810.1007/s13277-015-4352-8 ↗
14. 10.1093/jjco/hys14210.1093/jjco/hys142 ↗
15. 10.1158/1535-7163.mct-17-064610.1158/1535-7163.mct-17-0646 ↗
16. 10.1016/j.pharmthera.2019.10746510.1016/j.pharmthera.2019.107465 ↗
17. 10.1016/j.mrrev.2013.01.00210.1016/j.mrrev.2013.01.002 ↗
18. 10.1016/j.impact.2021.10029310.1016/j.impact.2021.100293 ↗
19. 10.1023/a:102304743186910.1023/a:1023047431869 ↗
20. 10.1021/jacs.2c0227710.1021/jacs.2c02277 ↗
21. 10.1016/j.nantod.2020.10093310.1016/j.nantod.2020.100933 ↗
22. 10.1080/17435390.2018.142550310.1080/17435390.2018.1425503 ↗
23. 10.1515/ntrev-2018-011010.1515/ntrev-2018-0110 ↗
24. 10.1021/jacs.9b1148110.1021/jacs.9b11481 ↗
25. 10.1073/pnas.120460010910.1073/pnas.1204600109 ↗
26. 10.1038/srep0477510.1038/srep04775 ↗
27. 10.1371/journal.pone.009917510.1371/journal.pone.0099175 ↗
28. 10.3892/mmr.2015.443310.3892/mmr.2015.4433 ↗
29. 10.1016/j.biomaterials.2021.12068010.1016/j.biomaterials.2021.120680 ↗
30. 10.1016/j.ajps.2021.10.00410.1016/j.ajps.2021.10.004 ↗
31. 10.1063/5.006153010.1063/5.0061530 ↗
32. 10.1016/j.nantod.2019.10080010.1016/j.nantod.2019.100800 ↗
33. 10.1016/j.jconrel.2009.06.00610.1016/j.jconrel.2009.06.006 ↗
34. 10.1038/physci241020a010.1038/physci241020a0 ↗
35. 10.1021/la304181k10.1021/la304181k ↗
36. 10.1021/nn506660610.1021/nn5066606 ↗
37. 10.1016/s0022-2836(02)00262-010.1016/s0022-2836(02)00262-0 ↗
38. 10.1016/j.softx.2015.06.00110.1016/j.softx.2015.06.001 ↗
39. 10.1021/jp801931d10.1021/jp801931d ↗
40. 10.1063/1.44586910.1063/1.445869 ↗
41. 10.1103/physreva.31.169510.1103/physreva.31.1695 ↗
42. 10.1063/1.32869310.1063/1.328693 ↗
43. 10.1063/1.46439710.1063/1.464397 ↗
44. 10.1021/ct900574510.1021/ct9005745 ↗
45. CharlesHahn, 2022. CharlesHahn/DuIvyTools:DIT-v0.2.0(v0.2.0).Zenodo.
46. 10.1186/1476-4598-13-3210.1186/1476-4598-13-32 ↗
47. 10.1016/j.molcel.2020.11.02410.1016/j.molcel.2020.11.024 ↗
48. 10.1038/nprot.2007.3010.1038/nprot.2007.30 ↗
49. 10.1158/2326-6066.cir-17-003510.1158/2326-6066.cir-17-0035 ↗
50. 10.1021/acsabm.0c0153710.1021/acsabm.0c01537 ↗